This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUBEQA 300 MG TABLET 120S, with a total ceiling value of $7,641.98 and a completion date of June 18, 2025. The contract is a Firm Fixed Price type and is not set aside for a specific business size or socioeconomic category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a ceiling value of $7,641.98 and a period of performance ending on July 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $7,641.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a firm fixed price of $10,920.00 and a period of performance through July 25, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $7,641.98 and a period of performance ending on June 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a $7,641.98 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a period of performance through July 2, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 120 tablets of the medication NUBEQA 300 MG. The $7,641.98 firm fixed-price contract has an ultimate completion date of July 22, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical products and medical supplies in...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,640.00 contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a performance period ending on June 20, 2025. The contract is not set-aside and was awarded on May 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 tablets of the medication NUBEQA 300 MG. The contract has a ceiling value of $7,641.98 and a completion date of March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $3,518.40 and a performance period through May 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...